1Kaghad M,Bonnet H,Yang A,et al.Monoallelically expressed gene related to p53at1p36,a region frequently deleted in neuroblastoma and other human cancers[J].Cell,1997,90(4):809-819.
2Oren M.Lonely no more:p53finds its kin in a tumor suppressor haven[J].Cell,1997,90(5):829-832.
3De-Laurenzi V,Costanzo A,Barcaroli D,et al.Two newp73splice variants,gamma and delta,with different transcriptional activity[J].J Exp Med,1998,188(9):1763-68.
4Ueda Y,Hijikata M,Takagi S,et al.New p73variants with altered C-terminal structures have varied transcriptional activities[J].Oncogene,1999,18(35):4993-98.
5Fillippovich I,Sorokina N,Gatei M,et al.Transactivation-deficient p73alpha(p73Deltaexon2)inhibits apoptosis and competes with p53[J].Oncogene,2001,20(4):514-522.
6Stiewe T,Theseling,CC,PuzterBM,Transactivation-deficient Delta TA-p73inhibits p53by direct competition for DNA binding:implications for tumorigenesis[J].J Biol Chem,2002,277(16):14177-85.
7Grob TJ,Novak U,Kaisse C,et al.Human delta Np73regulates a dominant nega-tive feedback loop for TAp73and p53[J].Cell Death Differ,2001,8(12):1213-1223.
8Clurman B,Groudine M.Tumour-suppressor genes.Killer in search of a motive[J]?Nature,1997,389(6647):122-123.
9Jost CA,Marin MC,Kaelin WCJ.p73is a simian[correction of human]p53-relat-ed protein that can induce apoptosis[J].Nature,1997,389(6647):191-194.
10De-Laurenzi V,Raschella G,Barcaroli D,et al.Induction of neuronal differentia-tion by p73in a neuroblastoma cell line[J].J Biol Chem,2000,275(20):15226-31.
11Flores ER,Tsai KY,Crowley D,et al.p63and p73are required for p53-depend-ent apoptosis in response to DNA damage[J].Nature,2002,416(6880):560-564.
12Nakagawa T,Takahashi M,Ozaki T,etal.Autoinhibitory regulation of p73by Del-ta Np73to modulate cell survival and death through a p73-specific target element within the Delta Np73promoter[J].Mol Cell Niol,2002,22(8):2575-2585.
13Zeng X,Chen L,Jost CA,et al.MDM2suppresses p73function without promoting p73degradation[J].Mol Cell Biol,1999,19(5):3257-66
14White E,Prives C.DNA damage enables p73[J].Nature,1999,399(6738):734-737.
15Stiewe T,Putzer BM.Role of the p53-homologue p73in E2F1-induced apoptosis[J].Nat Genet,2000,26(4):464-469.
16Yoshikawa H,Nagashima M,Khan MA,et al.Mutational analysis of p73and p53in human cancer cell lines[J].Oncogene,1999,18(22):3415-21.
17Ichimiya S,Nimura Y,Kageyama H,et al.p73at chromosome1p36.3is lost in advanced stage neuroblastoma but its mutation is infrequent[J].Oncogene,1999,18(4):1061-66.
18Van-Gele M,Kaghad M,Leonard JH,et al.Mutation analysis of P73and TP53in Merkel cell carcinoma[J].Br J Cancer,2000,82(4):823-826.
19Mai M,Yokomizo A,Qian C,et al.Activation of p73silent allele in lung cancer[J].Cancer Res,1998,58(11):2347-49.
20Yokomizo A,Mai M,Tindall DJ,etal.Overexpression of the wild type p73gene in human bladder cancer[J].Oncogene,1999,18(8):1629-33.
21Roth J,Konig C,Wienzk S,et al.Inactivation of p53but not p73by adenovirus type5E1B55-kilodalton and E434-kilodalton oncoproteins[J].J Virol,1998,72(11):8510-16.
22Takada N,Ozaki T,Ichimiya S,et al.Identification of a transactivation activity in the COOH-terminal region of P73which is impaired in a the naturally occurring mutants found in human neuroblastomas[J].Cancer Res,1999,59;2810-14.
23Martinez-Delgado B,Melendez B,Cuadros M,et al.Frequent inactivation of the p73gene by abnormal methylation or LOHin non-Hodgkin`s lymphomas[J].Int J Cancer,2002,102(1):15-19.
24Shishikura T,Ichimiya S,Ozaki T,et al.Mutational analysis of thep73gene in hu-man breast cancers[J].Int J Cancer,1999,84(3):321-325.
25Schwartz DI,Lindor NM,Walsh-Vockley C,et al.p73mutations are not detected in sporadic and hereditary breast cancer[J].Breast Cancer Res Treat,1999,58(1):25-29.
26Ahomadegbe JC,Tourpin S,Kaghad M,et al.Loss of heterozygosity,allele silen-cing and decreased expression of p73gene in breast cancers:prevalence of altera-tions in inflammatory breast cancers[J].Oncogene,2000,19(47):5413-18.
27Shishikura T,Ichimiya S,Ozaki T,et al.Mutational analysis of the p73gene in human breast cancers[J].Int J Cancer,1999,84(3):321-325.
28Ahomadegbe JC,Tourp in S,KaghadM,et al.Loss of heterozygosity,allele silen-cing and decreased expression of p73gene in breast cancer:prevalence of alterna-tions in inflammatory breast cancers[J].Oncogene,2000,19(47):5413-18.
29Dickman S.First p53relative may be a new tumor suppressor[J].Science,1997,277(5332):1605-06.
30Zaika AI,Slade N,Erster SH,et al.Np73,a dominant-negative inhibitor of wild-type p53and TAp73,is up-regulated inhuman tumors[J].J Exp Med,2002,196(6):765-780.
31Fillippovich I,Sorokina N,Gatei M,etal.Transactivation-deficientp73alpha(p73Deltaexon2)inhibits apoptosis and competes with p53[J].Oncogene,2001,20(4):514-522.
32杨万广,刘保池,王钟富.p63,p73蛋白在乳腺癌组织中的表达及其意义[J].中国误诊学杂志,2007,7(14):3194-95.
33Dominguez G,Silva JM,Silva J,et al.Wild type p73over expression and high-grade malignancy in breast cancer[J].Breast Cancer Res Treat,2001,66(3):183-190.
34杨开颜.乳癌组织p73基因的分析[J].温州医学院学报,2003,33(6):369-370.
35杨万广.survivin和p73在乳腺癌组织中的表达及意义[J].医药论坛杂志,2008,29(10):43-44.
36Ichimiya S,Nimura Y,Kageyama H,et al.p73at chromosome1p36.3is lost in advanced stage neuroblastoma but its mutation is infrequent[J].Oncogene,1999,18(4):1061-66.
37Yamamoto T,Oda K,Kubota T,et al.Expression of p73gene,cell proliferation and apoptosis in breastcancer:immunohistochemical and clinicopathological study[J].Oncol Rep,2002,9(4):729-735. |